4-Sulfamoylanilinium chloride.
Ontology highlight
ABSTRACT:
SUBMITTER: Zaouali Zgolli D
PROVIDER: S-EPMC2979367 | biostudies-literature | 2010 May
REPOSITORIES: biostudies-literature
Publications
4-Sulfamoylanilinium chloride.
Zaouali Zgolli Donia D Boughzala Habib H Driss Ahmed A
Acta crystallographica. Section E, Structure reports online 20100529 Pt 6
In the crystal structure of the title compound, C(6)H(9)N(2)O(2)S(+)·Cl(-), the chloride anions are sandwiched between layers of 4-sulfonamido-anilinium anions. The components interact by way of N-H⋯Cl and N-H⋯O hydrogen bonds, building up a three-dimensional network. ...[more]
Similar Datasets
Project description:In the crystal structure of the title compound, C(6)H(9)N(2)O(2)S(+)·NO(3) (-), the cations and anions are connected by N-H?O hydrogen bonds into a three-dimensional network.
| S-EPMC3201237 | biostudies-literature
Project description:In the crystal of the title salt, C6H9N2O2S(+)·ClO4 (-), the components are linked by N-H⋯O hydrogen bonds, forming a three-dimensional network. The cations are connected along a and b axes, leading to linear and zigzag C(3) and C(8) chain motifs, respectively. A cation-anion inter-action along the c axis leads to a C 2 (2)(12) chain motif. R 3 (3)(18) and R 3 (3)(20) ring motifs are observed as cation-anion-type inter-actions. These hydrogen-bonding ring and chain motifs are localized at z = 0 or 1, leading to alternate hydro-philic and hydro-phobic regions along the c axis as a result of the stacking of anions and the aromatic cationic parts.
| S-EPMC3793740 | biostudies-literature
Project description:In the title salt, 2C6H9N2O2S(+)·SO4 (2-), the sulfate S atom is situated on a crystallographic twofold axis (the symmetry of the anion is 2). The anion exerts intense libration, which is manifested by shortening of the observed sulfate S-O bonds, as well as by features in the electron-density map. The crystal structure is stabilized through a three-dimensional hydrogen-bonding network formed by strong N-H⋯O hydrogen bonds.
| S-EPMC3629637 | biostudies-literature
Project description:In the crystal structure of the title mol-ecular salt, C6H9N2O2S(+)·H2PO4 (-), the sulfomylalinium cations and the di-hydrogen phosphate anions form independent [100] chains through Ns-H⋯O (s = sulfamo-yl) and O-H⋯O hydrogen bonds, respectively. The chains are cross-linked by Na-H⋯O (a = amine) hydrogen bonds, generating (010) sheets. Two C-H⋯O hydrogen bonds involving diametrically opposite C atoms in the benzene ring of the cation as donors form chains parallel to [202] in which P=O and P-OH groups are acceptors. Together, these inter-actions lead to a three-dimensional network.
| S-EPMC4186100 | biostudies-literature
Project description:The Cl- intracellular channel (CLIC) family members uniquely transition between soluble and membrane-associated conformations. Despite decades of extensive functional and structural studies, CLICs’ function as ion channels remains debated, rendering our understanding of their physiological role incomplete. Here, we expose a novel function of CLIC5 as a fusogen. We demonstrate that purified CLIC5 directly interacts with the membrane and induces fusion, as reflected by increased liposomal diameter and lipid and content mixing between liposomes. Moreover, we show that this activity is facilitated by acidic pH, a known trigger for CLICs’ transition to a membrane-associated conformation and that increased exposure of the hydrophobic inter-domain interface is crucial for this process. Finally, mutation of a conserved hydrophobic interfacial residue diminishes the fusogenic activity of CLIC5 in vitro and impairs excretory canal formation in C. elegans in vivo. Together, our results unravel the long-sought physiological role of these enigmatic proteins.
2024-03-10 | PXD045186 | Pride
Project description:The proton transfer from carbon to a chloride ion and the proton transfer to a molecule of water promoted by chloride ions in the acid-catalyzed formation of hydroxamic acids from aldehydes and substituted nitrosobenzenes in mixed solvents have been proposed based on experimental and theoretical investigations. The formation of uncommon contact ion pairs consisting of the nitrosocarbinolic cation intermediate and a chloride anion, followed by the proton transfer from a C-H moiety of the cation intermediate, has been proposed. The influence of chloride on the proton transfer to a water molecule of the solvent-separated nitrosocarbinolic-cation-chloride ion pair was investigated too. The insights are based on the obtained kinetic and other evidence with regard to (1) influences of chloride anions on the observed reaction rates and primary kinetic isotope effects (PKIE) in the reaction; (2) the observed variation of the PKIE-s and rates of the reaction when perchlorate anions are present along with the chloride ions; and (3) the consideration of a model of the nitrosocarbinolic-cation-intermediate-chloride ion pair and transition structure for the proposed proton transfers based on the ab initio calculations.
| S-EPMC8880404 | biostudies-literature
Project description:IN THE TITLE COMPOUND [SYSTEMATIC NAME: 3-(10,10-dimethyl-anthracen-9-yl-idene)-N,N,N-trimethyl-propanaminium chlor-ide], C(21)H(26)N(+)·Cl(-), the cyclo-hexane ring adopts a chair conformation. The dihedral angle between the terminal benzene rings is 40.43?(12)°. In the crystal, ions are linked through inter-molecular N-H?Cl and C-H?Cl hydrogen bonds, forming supra-molecular layers parallel to the bc plane.
| S-EPMC3152036 | biostudies-literature
Project description:The title compound, C(4)H(10)N(+)·Cl(-), was obtained as a decomposition product from 2,6-bis-(pyrrolidin-yl)pyridine. The anion lies on the same cristallographic mirror plane as the N atom of the cation, the complete cation being generated by mirror symmetry. The anions and cations are connected by N(+)-H?Cl(-) hydrogen bonds into chains along [100]. The pyrrolidinium cation is puckered in an envelope conformation E(N1).
| S-EPMC2968435 | biostudies-literature
Project description:Aims/hypothesis AGEs are considered environmental contributors of type 1 diabetes, but the exact role AGEs play early in pathogenesis of the disease, remains unidentified. We aimed to reduce AGEs with the pharmacotherapy alagebrium chloride in MIN6N8 cells and early in life in NOD mice to determine its impact on beta cell immunogenicity, function, and disease progression. Methods MIN6N8 cells were cultured with AGEs with or without short-term alagebrium therapy to determine the effect on ER stress and beta cell antigen presentation via a reporter assay for protein responses in the unfolded protein response, the enzymatic activity of endoplasmic reticulum aminopeptidase-1 (ERAP1) and the immunopeptidome. To determine the effect of short-term alagebrium therapy on beta cells in vivo, female NOD mice were treated with alagebrium and insulin secretion, insulitis, and immune cell repertoire were studied. Adoptive transfer studies and diabetes progression studies were used to consider the impact of alagebrium on immune cell function and disease outcome. Results In MIN6N8 cells, alagebrium therapy inhibited the induction of endoplasmic reticulum (ER) stress and the activity of ERAP1 by AGE-modified proteins. Alagebrium treated-MIN6N8 cells did not change the MHC Class I presentation of known beta cell antigens but did induce proteomic changes related to ER homeostatic pathways. Prior to overt autoimmune diabetes, female NOD mice treated with alagebrium for 30-40 days had improved insulin secretion, reduced insulitis and amplified proportions of pancreatic CD8+ T cells, mature B cells and F4/80+ macrophages. Splenocytes from alagebrium-treated mice adoptively transferred disease to NODscid recipients and maintained interferon production in vitro. While partial protection of islets by alagebrium was seen following the adoptive transfer of activated NOD G9C8 transgenic TCR CD8+ T cells, alagebrium therapy in NOD mice did not reduce diabetes progression. Conclusions/interpretation Our data suggests that in experimental models of diabetes, short-term alagebrium treatment allows for beta cell improvement, and maintenance of immune cell function, which does not fully mitigate diabetes progression.
2021-06-29 | PXD025998 | Pride